KIM
BNTX icon

Kestra Investment Management’s BioNTech BNTX Stock Holding History

Kestra Investment Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5
Closed -$570 – 955
2024
Q4 		$570 Buy
+5
New +$571 ﹤0.01% 1125

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Kestra Investment Management's BNTX Position: Q1 2025 in Review

Kestra Investment Management sold out of BioNTech (BNTX) in Q1 2025, closing a stake of 5 shares — an estimated $570 sold.

Kestra Investment Management first reported a position in BNTX in Q4 2024 and held it in 1 quarter. The position peaked at $570 in Q4 2024. 280 funds tracked by Wall St. Rank hold BNTX as of Q1 2025.

  • Kestra Investment Management reported no remaining BioNTech position as of Q1 2025 after selling out during the quarter.
  • Kestra Investment Management sold 5 BioNTech shares in Q1 2025, an estimated $570.
  • Kestra Investment Management first reported a position in BioNTech in Q4 2024 and held it in 1 quarter.
  • Kestra Investment Management's BioNTech position peaked at $570 in Q4 2024.
  • 280 funds tracked by Wall St. Rank held BioNTech as of Q1 2025.

Based on Kestra Investment Management's 13F filing for Q1 2025, filed 16 May 2025.